Clinical Trial Update: Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This Phase 1 safety study evaluates the safety of combining radiotherapy with erlotinib (Tarceva) for brain metastases in patients with non-small cell lung canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Non-Small Cell Lung Cancer, Brain Metastases | Phase 1 | Status: COMPLETED